FDA Approved: DIMETHYL FUMARATE — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

FDA approves Solco Healthcare US, LLC's supplemental application for dimethyl fumarate, indicating approval of a generic version under an ANDA (ANDA210414).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

SUPPL AP for DIMETHYL FUMARATE (DIMETHYL FUMARATE)